A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 8 152,6 ₴, with a 24-hour trading volume of 13,77B ₴. The asset's market cap is 12,64T ₴, after moving -1.40% in the last day.
Tokenized AstraZeneca PLC is trading at 4 603,67 ₴, with a tokenized market cap of 630,63M ₴ and a 24-hour trading volume of 33,28M ₴. The tokenized asset has moved -1.85% in the past 24 hours.